There are many factors to consider when selecting a clinical trial destination, and Latin America is becoming one of the most desirable places.


With a diverse population, strong research network and solid doctor-patient relations, Latin America is supporting an increasing number of clinical research worldwide and is now an attractive location for multi-region clinical trials.


Join our on-demand webinar on May 25 (Thu) by Head of Latin America, Tigermed Charles Schmidt, and our distinguished guests Gustavo MendesHélio Osmo and Fernando de Rezende to learn why Latin America is a compelling region to conduct your global clinical trials.


Why Latin America Should Be Your Next Clinical Development Destination? 

May 25 (Thursday), 2023

9:00-10:00am Brazil  /  8:00-9:00am US East

8:00-9:00pm China   /  2:00-2:00pm Central Europe

Register Here

Charles Schmidt, PhD

Head of Latin America, Tigermed



Gustavo Mendes, PhD

Director of Regulatory, Quality and Clinical Trials of Instituto Butantan



Hélio Osmo, PhD

President of the Brazilian Association of Pharmaceutical Physicians



Fernando de Rezende

Executive Manager of Brazilian Association of CROs - Abracro




Feel free to contact us via marketing@tigermedgrp.com or Online Request to learn more about our services and solutions. Thank you and looking forward to your attendance!


View this letter as webpage in your browser.

Tigermed I www.tigermedgrp.com

LinkedIn  Twitter